SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Any info about Iomega (IOM)?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: s. bateh who wrote (50307)3/17/1998 10:53:00 AM
From: Bill Lin  Read Replies (1) of 58324
 
Hi s. batch!

I enjoy your informative posts on the ingram stock levels.

if you missed my post before, IOM may have done a linear extention of its quarterly sales. With 12 weeks in this quarter ending march 28 1998, that is $30 million in sales per week to match their Q1 '97 revenue level of $360 million.

To break even with their estimated SGA spending of $110 million (up from Q4 spending of $104 mm), and R&D spending of $25 mm (up from Q4 spending of 24mm), or total op ex of $135 million, Iomega must make a gross margin on sales of 30% (down from 33% Q4).

So the calculation is as follows: $135mm in expenses / gross margin = breakeven point. $135/0.3 = $450 million.

Assumming Iomega projected a linear sales quarter...They have $300million in sales so far this quarter (2 weeks left), and need to sell $150 million in the next 2 weeks to recover to break even.

If they sell 100,000 jaz 2 drives at $400 wholesale, that is equivalent to $40 million. If they sell 100,000 jaz 1 drives at $200 wholesale, thats $20 million. So somehow in the next 2 weeks, they need to sell $90 million in zip/zipdisk/jaz1 disk/jaz2 disk.

If ingram does represent 10% of iomega sales, as it seems, your reports will give a good indication of how iomega does in the next 2 weeks!

Thanks for all your info.

BL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext